Õë´ÌÖÎÁÆÆ«Í·Í´fMRI»úÖÆÑо¿½øÕ¹ Æ«Í·Í´ÊÇÒ»ÖÖÔÚÈ«Çò·¶Î§ÄÚ¾ßÓнϸ߷¢²¡Â浀 Éñ¾ÏµÍ³¼²»¼ £Û1 £Ý £¬ ÔÚÖйú¸ß´ï 9£® 3% £Û2 £Ý £¬ ͬʱҲÊÇÒ» ÖÖÑÏÖØÓ°Ï컼ÕßÉú»îÖÊÁ¿²¢´øÀ´Éç»á¾¼Ã¸ºµ£µÄÖ ²ÐÐÔ¼²²¡ £Û3 £Ý ¡£ÁÙ´²±íÏÖ³ý½ÏÏÔÖøµÄÍ·²¿µ¥²à»òË« ²à²«¶¯ÑùÌÛÍ´Í⣬ Æ«Í·Í´»¼ÕßÔÚÌÛÍ´·¢×÷ʱ£¬ ͬʱ°é ÓжñÐÄŻ͡¢ η¹âηÉùµÈÁÙ´²±íÏÖ¡£ÓÉÓÚÆ«Í·Í´¸´ Ôӵķ¢²¡»úÖÆÓë·¢×÷ÖÜÆÚ£¬ ʹµÃÆ«Í·Í´»¼ÕßµÄÕï¶Ï Óë·ÖÀà¾ßÓÐÒ»¶¨ÄѶȣ¬ µ¼Ö³öÏֽϸߵÄÎóÕïÂÊ £Û4 £Ý ¡£ ½üÄêÀ´£¬ ¹¦ÄÜÐԴŹ²Õñ³ÉÏñ( functional magnetic reso- nance imaging£¬ fMRI) ¼¼ÊõÒÑÄÜÖð²½Ìṩ¸ü¼Ó¿É¿¿µÄ ÓëÀíÂÛ¼ÙÉè½ÏÌù½üµÄÁÙ´²Ö¤¾Ý£¬ ÀýÈçÏÈÕ×Ö¢×´Æ«Í· Í´»¼Õß¾ßÓÐÏà½ÏÓÚ½¡¿µÈËȺÓëÎÞÏÈÕ×Õ߸ü¼ÓÏÔÖøµÄ ³õ¼¶ÊÓ¾õƤ²ã¸ß·´Ó¦ÏÖÏó £Û5 £Ý £¬ ½øÒ»²½Ö§³ÖƤ²ãÀ©²¼ ÐÔÒÖÖƵÄѧ˵¡£ÌÛÍ´±íÏÖ( ƵÂÊ¡¢ ³ÖÐøʱ¼ä¡¢ ³Ì¶È) ¡¢ ¼²²¡ÂýÐÔ»¯ £Û6 £Ý ÓëÄÔ¹¦ÄÜÁ¬½Ó½µµÍ£¬ ½øÒ»²½·á¸»ÌÛÍ´ ¸Ð¾õµ÷ÖÆÖÐÊàµÄÀíÂÛ £Û7 £Ý ¡£ Õë´ÌÖÎÁÆÔÚÊÀ½ç·¶Î§Äڵõ½¹ã·ºÓ¦Óà £Û8 £Ý £¬ Õë´Ì ÖÎÁÆÆ«Í·Í´ÒѳÉΪֵµÃÍƼöµÄÓÐЧ¡¢ °²È«£¬ ²¢¼õÉÙÒ© Îï²»Á¼·´Ó¦µÄÓÅÊÆÁÆ·¨ £Û9 £Ý ¡£fMRI ¼¼ÊõÒòÆä³ÉÏñÇå Îú¡¢ °²È«ÎÞ·øÉäΣº¦µÈÓÅÊÆ£¬ ʹÆäÔÚ½üÄêÀ´µÄÕë´ÌÑÐ ¾¿Öеõ½½Ï¶àÓ¦Ó㬠ÓÈÆäÔÚѨλÌØÒìÐÔ¡¢ ѨλÅäÎéÓë ÁÆЧÑéÖ¤µÈ·½ÃæµÄÑо¿¶¼µÃµ½¸ü¿Í¹ÛµÄ¿ÆѧÒÀ¾Ý¡£ Ò»¡¢ ÎÄÏ××ÊÁÏ Í¨¹ý¼ìË÷½ü 10 Äê PubMed¡¢ MEDLINE¡¢ Cochrane¡¢ ÖйúÖªÍø( CNKI) ºÍάÆÕµÈÊý¾Ý¿â£¬ µÃµ½Õë¾ÄÖÎÁÆÆ« Í·Í´µÄ fMRI »úÖÆÑо¿ÎÄÏ× 14 ƪ£¬ ÆäÖÐÓ¢ÎÄÎÄÏ× 10 ƪ¡¢ ÖÐÎÄÎÄÏ× 4 ƪÅųý 6 ƪÎÄÏ×( ×ÛÊöÐÔ 3 ƪ£¬ ÖØ ¸´·¢±í1 ƪ£¬ Ñо¿·½°¸1 ƪ£¬ ÓëÕë¾Ä²»Ïà¹Ø1 ƪ) £¬ ×î ÖÕÄÉÈë 8 ƪÎÄÏס£ ¶þ¡¢ Ñо¿Éè¼ÆÓë·½·¨ ( Ò») Æ«Í·Í´ÊÔÑé¶ÔÏó ÊÔÑé¶ÔÏóÖ÷ҪΪ·ûºÏ¹ú¼ÊÍ·Í´¼²²¡µÄ·ÖÀàµÚ¶þ °æ( international classification of headache disorders£¬ 2 nd edition£¬ ICHD- II) Õï¶ÏµÄÆ«Í·Í´»¼Õß £Û10- 17 £Ý £¬ ÆäÖÐ 6 ƪΪ·ûºÏÉÏÊö±ê×¼µÄÎÞÏÈÕ×Æ«Í·Í´( migraine without aura£¬MwoA) »¼Õß £Û 10- 15 £Ý £¬ 2 ƪ £Û 16£¬ 17 £Ý ÎÄÏ×Õï¶Ï·û ºÏÉÏÊö±ê×¼µÄÆ«Í·Í´£¬ µ«Î´Ã÷È··ÖÐÍ¡£ÔÚÕë´ÌÁƳ̷½ Ã棬 5 ƪ £Û 10- 11£¬ 13- 17 £Ý ÎÄÏ×ÁƳÌΪ 4 ÖÜ£¬ 1 ƪ £Û 16 £Ý ÎÄÏ×¼ÇÔØ Îª8 ÖÜ£¬ 1 ƪ £Û 17 £Ý ÎÄÏ×ÁƳÌΪ 5 ÈÕ; 1 ƪ £Û 12 £Ý ÎÄÏ×¹Û²ìÕë ´ÌµÄ¼´¿ÌЧӦ¡£3 ƪ £Û 10- 11£¬ 13 £Ý ÎÄÏ׵ĶÔÕÕ×齫»¼Õß·ÖΪ ²»Í¬µÄ 3 ¸öѨλÅäÎé´¦·½µÄ VA( verum acupunc- ture) ×飬 Ϊ±È½Ï²»Í¬µÄѨλÅäÎé´¦·½ÌṩÌõ¼þ¡£ ( ¶þ) ¶ÔÕÕ×éÑ¡Ôñ 8 ƪÎÄÏ×ÖУ¬ 7 ƪ £Û10- 16 £Ý ÎÄÏ×¾ùÒÔÎÞÍ·Í´µÄ½¡¿µ ÈËȺΪ¶ÔÕÕ×é( healthy control£¬HC) £¬ 1 ƪÎÄÏ× £Û17 £Ý ²É ÓõÄÊÇÍ·Í´¶ÔÕÕ×é¡£ÆäÖÐ 3 ƪÎÄÏ× £Û10- 11£¬ 13 £Ý µÄÑо¿³ý ÁË HC Í⣬ Ò²ÉèÁ¢Î´¾Õë´ÌµÄµÈ´ýÖÎÁÆ( waiting- list£¬ WT) ×éºÍ¼ÙÕë´Ì×é( sham acupuncture£¬SA) ¡£ ( Èý) ɨÃèʱµã 7 ¸öÑо¿¾ùÔÚδ¾Õë´Ì¸ÉԤǰÓëÕë´ÌÁƳ̽áÊø ºó½øÐÐ 2 ´Î fMRI ɨÃè £Û10- 11£¬ 13- 17 £Ý ¡£1 ƪÑо¿¹Û²ìÕë´Ì ¼´¿ÌЧӦ£¬ ·Ö±ðÓÚ»¼ÕßÕë´ÌÇ° 30 min ¾ÀúɨÃèÇ°Ô¤ ±¸¹ý³Ì£¬ 8 min ¾²Ï¢Ì¬É¨Ã裬 ½øÕëºó10 s£¬ ƽ²¹Æ½ÐºÄí Õë 1 min£¬ ÔÙÁôÕë 8 min ºó³öÕëµÄάʱ 9 min 10 s µÄ ɨÃè ¹ý ³Ì £Û12 £Ý ¡£´Å ¹² Õñ ²¨ Æ× ( magnetic resonance spetroscopy£¬ MRS) Ñо¿µÄµ¥ÌåËØɨÃèʱ¼äΪ 4 min 25 s£¬ ¶àÌåËØɨÃèʱ¼äΪ 8 min 26 s¡£ ( ËÄ) fMRI Ñо¿Ä¿µÄÓëÊý¾Ý·ÖÎö·½·¨Ñ¡Ôñ ÓÉÓÚ²»Í¬µÄ fMRI Êý¾Ý·ÖÎö·½·¨´æÔÚÓÅȱµã£¬ ͨ ³£¸ù¾ÝÑо¿µÄ²àÖصãÑ¡ÔñÏàÓ¦µÄ·ÖÎö·½·¨¡£¾²Ï¢Ì¬ ( resting state£¬RS) fMRI µÄÊý¾Ý·ÖÎöÖ÷ÒªÓÐÄÔ¹¦ÄÜ ÕûºÏ·ÖÎöºÍ¾Ö²¿ÄԻ·ÖÎö: Ç°ÕßÓй¦ÄÜÁ¬½Ó ( functional connectivity£¬FC) ·ÖÎö¡¢ ¶ÀÁ¢³É·Ö·ÖÎö ( independent component analysis£¬ICA) ; ºóÕßÓоֲ¿ Ò»ÖÂÐÔ( regional homogeneity£¬ReHo) ·ÖÎö¡¢ µÍƵÕñµ´ Õñ·ù( amplitude of low frequency fluctuation£¬ALFF) ¡£ 1£® ÄÔ¹¦ÄÜÕûºÏ·ÖÎö¡£¾²Ï¢Ì¬¹¦ÄÜÁ¬½Ó( resting state functional connectivity£¬rs- fc) µÄ·ÖÎö³£ÓõÄÊÇ ÒÀÀµËùÑ¡ÖÖ×Óµã( seed- based analysis£¬SBA) Ϊ»ù´¡ µÄ·ÖÎö·½·¨¡£È»¶ø SBA ·ÖÎö rs- fc µÄ·½·¨¶ÔËùÑ¡Ôñ µÄÖÖ×Ó½ÏÃô¸Ð£¬ Ñ¡Ôñ²»Í¬µÄÖÖ×Óµã»á²úÉú²»Í¬µÄÁ¬ ½Ó½á¹û£¬ Òò´Ë²»ÄܸüºÃµÄ·´Ó³ÆäËûÄÔ¹¦ÄÜÇøÓòµÄ rs- fc £Û18 £Ý ¡£ICA ·ÖÎö·½·¨ £Û18 £Ý ¿ÉÒԽϺõĴӶà±äÁ¿ÖÐ Ñ°ÕÒδ֪±äÁ¿£¬ ¿ÉÒÔÔÚ²»¿¼ÂÇʱ¼äµÄÏÈÑé¼ÙÉèÏ£¬ ·Ö Àë³ö·Ç¸ß˹ÐźÅÔ´µÄÏßÐÔ×éºÏ£¬ µ«È±µãÊÇËù¶ÀÁ¢µÄ ³É·ÖÎÞ·¨È·¶¨¸öÊý£¬ ³É·Öȱ·¦ÉúÀíÒâÒå¡£Òò´ËÉÏÊö ·½·¨¿Éµ¥¶ÀʹÓ㬠Ҳ¿ÉÒÔ½áºÏʹÓà ICA Óë SBA ·ÖÎö ·½·¨ÒÔÃÖ²¹²¿·Ö²»×ã¡£Li µÈ £Û11 £Ý ÔÚ 2017 ÄêµÄÑо¿ ÖУ¬ Ê×ÏȲÉÓà ICA ¸ÅÂÊ´ÓËùÓÐÊÔÑé¶ÔÏóÈ¡µÃ¾²Ï¢Ì¬ ÍøÂ磬 ²¢ÇÒ´Ó½¡¿µÈËȺÖÐÈ¡µÃÄ£°åÍøÂ磬 ËæºóÔÚÁ½Õß Ö®¼äÓҶÍøÂç( right frontoparietal network£¬rFPN) ³ÊÏÖ×î¸ßµÄ¿Õ¼äÖغϴ¦¹éÈë rFPN£¬ ²¢ÇÒ²ÉÓøà rFPN ×÷Ϊ¹ãÒåÏßÐÔÄ£ÐÍ( generalized linear model£¬ GLM) µÄ¸öÌå¿Õ¼ä±äÁ¿£¬ ͨ¹ý¶Ô¸öÌåʱ¼äÐòÁнøÐÐÇø×é·Ö Îö£¬ È¡µÃÿ¸öÌåËØÓë rFPN Ö®¼äµÄ¾²Ï¢Ì¬¹¦ÄÜÁ¬½Ó Ç¿¶Èºó£¬ ·ÖÎö×é¼äºÍ×éÄÚ²îÒì¡£¸ù¾Ý ICA ·ÖÎö½á¹û ÖÐÍ»³öµÄШǰҶÇøÓò×÷ΪÖÖ×ӵ㣬 ²¢²ÉÓûùÓÚ SPM µÄÈí¼þ¶ÔÕë´ÌµÄµ÷½Ú»úÖƽøÐнøÒ»²½ rs- fc ¹Û²ì¡£ ͳ¼Æ²ÎÊýÓ³Éä( statistical parametric mapping£¬SPM) ÊÇÒ»ÖÖ½áºÏ GLM ºÍ¸ß˹ÀíÂ۵ķ½·¨¡£Li µÈ £Û13 £Ý ÔÚ 2015 ÄêµÄÑо¿Öнö²ÉÓø¹²àÖÐÄÔµ¼Ë®¹ÜÖÜΧ»Ò ÖÊ( ventrolateral periaqueductal gray£¬vlPAG) ΪÖÖ×Ó µã£¬ ²¢ÒÔÖÐÄÔµ¼Ë®¹ÜÖÜΧºÍµÚËÄÄÔÊÒµÈÖÖ×Óµã×÷Ϊ ¶ÔÕÕ¡£ Zhang µÈ £Û 14 £Ý ²ÉÓÃICA ·ÖÎö·½·¨£¬ ͨ¹ý GIFT Èí¼þ£¬ ÅÅ ³ý·ÇÏà¹ØÄÔ¹¦ÄÜÍøÂçµÃµ½×î¼ÑµÄ¾²Ï¢Ì¬ goodness- of- fit Öµ£¬ ¶øÇø×é rs- fc ±È½Ï²ÉÓà SPM Èí¼þ¡£Li µÈ £Û15 £Ý ²ÉÓà ÏàͬµÄ ICA ·½·¨¶ÔÆ«Í·Í´»¼ÕßµÄ RFPN ½øÐй۲죬 ²¢ÔÚÇ°Õß½á¹ûµÄ»ù´¡ÉÏÉ趨ÃÖÉ¢ÕÅÁ¿³ÉÏñ( diffusion tensor imaging£¬DTI) £¬ Ñо¿ 3 ¸ö¸ÐÐËȤÇøÓò( region of interest£¬ROI) £¬ ·Ö±ðΪÕë´ÌÇ°»¼ÕßÄÔ¹¦ÄÜ rs- fc ½µ µÍ²¿Î»¡¢ Õë´Ìºó rs- fc ÉÏÉý²¿Î»Óë×ó²àÖÐÑëÇ°»Ø£¬ ΪÉñ ¾ÔªÁ¬½Ó״̬ÌṩÒÀ¾Ý¡£ÁõºêΰµÈ £Û 12 £Ý ²ÉÓÃÍøÂç·ÖÎö ·½·¨£¬ ÒÔ×Ô¶¯¹¦ÄܱêÇ©½âÆÊѧ( anatomical automatic labeling£¬ AAL) Ä£°åÌáÈ¡ 90 ¸öÄÔÇøµÄʱ¼äÇúÏߣ¬ ²¢¶Ô ÿ¸öÊÜÊÔÕßµÄ AAL ÄÔÇøÖ®¼ä²ÉÓà Pearson Ïà¹Ø¼ÆËãÄÔ Çø±Ë´ËµÄ¹¦ÄÜÁ¬½Ó¶È»ñµÃ¾ØÕó£¬ ²¢½áºÏÄÔÇøÈ¡µÃÐÂ¾Ø Õó£¬ Í¬Ê±²ÉÓûùÓÚÍøÂçͳ¼Æ( network- based statistic£¬ NBS) ·½·¨½øÐÐ×é¼ä×éÄڱȽϡ£ 2£® ¾Ö²¿ÄԻ·ÖÎö¡£ReHo ÊÇ»ùÓڿϵ¶ûºÍг ϵÊý( kendall's coefficient of concordance£¬KCC) ¶È Á¿Ò»¸öÍÅ¿éÄÚÌåËØÖ®¼äʱ¼äÐòÁеı仯 £Û19 £Ý ¡£Ã¿¸ö ÌåËؾùÓÐÒ»¸ö ReHo Öµ£¬ ·´Ó³Ëù¹Û²ìÌåËØÓëÖÜΧÌå ËØÇøÓòµÄѪÑõÒÀÀµË®Æ½( blood oxygen level dependent£¬ BOLD) ÐźÅʱ¼äͬ²½ÐÔ¡£Ö÷Òª¹Û²ì¾Ö²¿»î¶¯£¬ ¶ø·Ç Õû¸öÄÔÇøÐźš£Zhao µÈ £Û16 £Ý Ó¦Óà ReHo ·½·¨£¬ Ê×ÏÈͨ ¹ýʱ¼äÐòÁмÆËã¸÷¸öÌåËØÓëÖÜΧµÄ 26 ¸öÁÚ½üÌåËØ µÄ KCC Öµ; È»ºó£¬ ͨ¹ý KCC ¾ùÖµ¶¨ÒåÕû¸öÄÔÄÚ KCC ͼ£¬ ͨ¹ý²»Í¬¼¯Èº¼äµÄ±È½Ï£¬ ¼ìÑéÕë´ÌÖÎÁƵľÖÓòÒ» ÖÂÐÔ¡£ ALFF Ò²ÊǾֲ¿ÄԻµÄ·ÖÎö·½·¨£¬ Ö÷Ҫͨ¹ý ¼ÆËãÿ¸öÌåËØ ALFF µÄ´óСÀ´·´Ó³Éñ¾Ôª»î¶¯µÄÇ¿ Èõ £Û19 £Ý ¡£Li µÈ £Û10 £Ý ÔÚ 2017 Äê·¢±íµÄÑо¿ÖвÉÓà ALFF ·ÖÎö·½·¨£¬ ¹Û²ìÆ«Í·Í´»¼Õß¾²Ï¢¹¦ÄÜ̬ϵÄ×Ô·¢»î ¶¯£¬ ·ÖÎö±È½ÏÌØÒìѨÕë´ÌÓë·ÇÌØÒìѨÕë´Ì¶ÔÓÚÆ«Í· Í´»¼ÕßµÄÄÔ¹¦Äܵ÷½Ú»úÖÆ¡£ ( Îå) ѨλµÄÑ¡Ôñ ÄÉÈëµÄ 8 ƪÎÄÏ×ÖвÉÓõÄѨλÓÐÊÖÉÙÑôµÄ¾Í⠹ء¢ Ë¿Öñ¿Õ¡¢ ÂʹȵÈ; ×ãÉÙÑô¾µÄ·ç³Ø¡¢ ÑôÁêȪ¡¢ ×ãÁÙ Æü¡¢ ÇðÐæµÈ; ÊÖÑôÃ÷¾µÄºÏ¹È¡¢ Æ«Àú; ×ãÑôÃ÷¾µÄ×ãÈý Àï; ×ãØÊÒõ¾µÄÌ«³å¡¢ Ðмä; ×ãÌ«Òõ¾µÄÌ«°×; ¶½ÂöµÄ °Ù»á; ÊÖØÊÒõ¾µÄ´óÁêÒÔ¼°¾ÍâÆæѨ̫ÑôµÈ¡£ Zhang µÈ £Û14 £Ý ¡¢ Li µÈ £Û15 £Ý µÄѨλ´¦·½Éæ¼°ÊÖ×ãÉÙÑô ͬÃû¾ÅäѨ¡¢ µ¨¾Óë¸Î¾µÄ±íÀï¾ÅäѨ¡¢ °´²¿Î»µÄÔ¶ ½üÅäѨµÈÅäÎ鷽ʽ¡£Li µÈ £Û10- 11£¬ 13 £Ý µÄÖÎÁÆ×é 1 ÒÔÊÖ×ã ÉÙÑôͬÃû¾ÅäѨ£¬ È¡ÑôÁêȪ¡¢ ÇðÐæ¡¢ Íâ¹Ø£¬ ¶øÑôÁêȪΪ µ¨¾ÏºÏѨ¡¢ ÇðÐæΪµ¨¾ÔѨ¡¢ Íâ¹ØΪÈý½¹¾ÂçѨ; ÖÎÁÆ×é 2 ȡѨҲÒÔÊÖ×ãÉÙÑôͬÃû¾ÅäѨ£¬ È¡Ï¥Ñô¹Ø¡¢ µØÎå»á¡¢ ÈýÑôÂ磬 ´Ë 3 ×éѨλ²»ÊôÌض¨Ñ¨¡£ÖÎÁÆ×é 3 ÒÔÊÖ×ãÑôÃ÷ͬÃû¾ÅäѨ£¬ ȡѨÓÐ×ãÈýÀï¡¢ ³åÑô¡¢ Æ«Àú£¬ ×ãÈýÀïΪθ¾ÏºÏѨ¡¢ ³åÑôΪθ¾ÔѨ¡¢ Æ«ÀúΪ´ó³¦ ¾ÂçѨ¡£Zhao µÈ £Û16 £Ý µÄÖÎÁÆ×éÈ¡×ãÉÙÑôµ¨¾Í·²¿Ñ¨ ( ·ç³Ø£¬ ÓëÑôάÂö½»»á) ¡¢ ÊÖÉÙÑô¾ÂçѨ( Íâ¹Ø£¬ °ËÂö ½»»áѨ£¬ ͨÑôάÂö) ¡¢ µ¨¾ÔѨ( ÇðÐæ) ¡¢ µ¨¾ÏºÏѨ ( ÑôÁêȪ) £¬ Ѩλ´¦·½ÒÔÍ·ÃæËÄÖ«µÄÔ¶½üÅäѨºÍÉÙÑô ͬÃû¾ÅäѨΪÖ÷; ¶ø¶ÔÕÕ×éÈ¡¶úºÌós¡¢ ´óÁê¡¢ ¹âÃ÷¡¢ Ì« °×£¬ ÊÖÉÙÑô¡¢ ×ãÌ«Òõ¡¢ ÊÖ¡¢ ×ãØÊÒõѾµÄÎÞÌض¨Ñ¨¡£¹È ÌÎµÈ £Û 17 £Ý ÔòÈ¡Í·²¿¶½Âö°Ù»á¡¢ ×ãÉÙÑôµ¨¾·ç³Ø¡¢ ÏÂÖ«×ã ØÊÒõ¸Î¾ÜþѨÐмä( ¸Î¾×ÓѨ) ×é·½ÒÔÔ¶½üÅäÎéºÍ¸Î ¾µ¨¾±íÀï¾ÅäѨΪÖ÷( ±í1) ¡£ Õë´ÌѨλÓëѨλ´¦·½ÔÚÖÎÁÆÆ«Í·Í´µÄ»úÖÆÑо¿ ÖÐÈ¡µÃÒ»¶¨³É¹û£¬ µ«Ñù±¾Á¿½ÏÉÙ¡¢ fMRI ·ÖÎö·½·¨µÄ ¾ÖÏÞÐÔ²»ÄÜÍêÈ«·´Ó³ÕæʵÕë´ÌЧӦ¡¢ ѨλµÄÅäÎé×÷ ÓÃÑо¿µÈÎÊÌâ¡£ Èý¡¢ Ñо¿½á¹û·ÖÎö 3 ƪÎÄÏ×Ëù²ÉÓõÄÁÙ´²ÖÎÁÆ·½°¸»ù±¾Ïàͬ£¬ µ« Ëù²ÉÓÃµÄ fMRI ·ÖÎö·½·¨²»Í¬ £Û10£¬ 11£¬ 13 £Ý ¡£ALFF ·ÖÎö ½á¹ûÏÔʾ£¬ ÔÚδÖÎÁÆÇ°£¬ MwoA »¼ÕßÔÚºó²àÄÔµºÓëÎÆ ×´Ìå( ¿ÇºË/β״ºËÏàÁ¬) µÈÇøµÄ ALFF ÖµÔö¸ß£¬ ¶øÑÓ ËèÍ· ¶Ë ¸¹ ÄÚ ²à Çø ( rostral ventromedial medulla£¬ RVM) /Èý²æÉñ¾¾±¸´ºÏÌå( trigeminocervical complex£¬ TCC) ÏàÁ¬ÇøÓò ALFF Öµ½µµÍ £Û10 £Ý ¡£Õë´ÌÖÎÁÆºó£¬ MwoA »¼Õß RVM/ TCC ÏàÁ¬ÇøÓò ALFF ÖµÇ÷ÏòÓÚ½¡ ¿µÈËȺ¡£Ñо¿½á¹ûÌáʾÈý²æÉñ¾Í´¾õͨ·µÄÎÈ̬ʧ µ÷Ó°Ïì MwoA µÄÉñ¾²¡ÀíÉúÀí½øÕ¹£¬ ÓÐЧµÄÖÎÁÆ×é Õë´ÌÖÎÁÆ¿ÉÒÔʹ¸Ãͨ·µÄÎÈ̬ʧµ÷µÃµ½¾ÀÕý¡£Í¬ ʱ£¬ ICA ·ÖÎö½á¹ûÏÔʾÓë HC Ïà±È£¬ MwoA ÖÎÁÆÇ°ÓÒ ²à¶î¶¥Ò¶ÍøÂç FPN( frontoparietal network£¬ FPN) ÓëË« ²àШǰҶ֮¼äµÄ rs- fc ½µµÍ £Û11 £Ý ¡£Õë´ÌºóÉÏÊöµÄ rs- fc ½µµÍµÃµ½¸ÄÉÆ£¬ Ïà¹Ø·ÖÎö·¢ÏÖ´ËÇø rs- fc ¸ÄÉÆ¿É»º½â Í·Í´µÄ³Ì¶È¡£½øÒ»²½ÒÔШǰҶΪÖÖ×Óµã SBA ·ÖÎö ½á¹ûÒ²ÔÚÓÒ²àШǰҶÓëÓÒ²à FPN( rACC/MPFC ¡¢ ¸¹ ²àÎÆ×´Ì壬 ÖÐ/ÏÂÕí»ØµÈ) Ö®¼äµÄ rs- fc ÏÔʾÀàËÆ½á ¹û¡£Ñо¿½á¹ûÌáʾ MwoA »¼ÕßÄÔÇø´æÔÚÒ»¸öÊÊÓ¦·´ ¸´Í·Í´´Ì¼¤µÄÊÊÓ¦µ÷½Ú»úÖÆ£¬ ÊÇÒ»ÖÖ»úÌåÓ¦¶ÔÌÛÍ´ ʱ²úÉúµÄ»Ø±Ü»úÖÆ¡£ÓÐЧÕë´Ìʹ¸Ã»úÖƵõ½Ç¿»¯£¬ ʹƫͷʹ»¼Õ߶ÔÉ˺¦ÐԴ̼¤µÄÊÊÓ¦µ÷½ÚÄÜÁ¦µÃµ½Ìá ÉýÒÔ´ïµ½»º½âÆ«Í·Í´µÄÁÆЧ¡£ÁíÒ» SBA Ñо¿ÒÔ¸¹ ²àÖÐÄÔµ¼Ë®¹ÜÖÜΧ»ÒÖÊ( ventrolateral periaquaductal gray£¬vlPAG) ΪÖÖ×ӵ㣬 Æä½á¹ûÏÔʾ£¬ Óë HC ±È½Ï£¬ MwoA µÄ vlPAG ÓëÇ°¿Û´øƤ²ã ( anterior cingulate cortex£¬ACC) Ö®¼äµÄ rs- fc ½µµÍ £Û13 £Ý ¡£¶ø¸ÃÇø rs- fc Öµ Ô½µÍ£¬ ÌÛÍ´³Ì¶ÈԽǿ¡£¾Õë´Ìºó¸ÃÇøÓò rs- fc µÃµ½ ÌáÉý¡£PAG ÇøÊÇÆ«Í·Í´»¼ÕßÏÂÐÐÌÛÍ´µ÷½Ú»úÖÆ ( descending pain modulatory system£¬ DPMS) µÄÖØÒªÄÔ ÇøÖ®Ò» £Û20 £Ý ¡£Ñо¿·¢ÏÖÆ«Í·Í´·¢×÷´ÎÊý£¬ Óë DPMS Ïà ¹ØÄÔÇøÓÒÇ°¶îҶƤ²ã( prefrontal cortex£¬PFC) ¡¢ ACC¡¢ ÄÔµº¡¢ ÄÚ²àÇðÄÔµÈºÍ PAG ÇøÖ®¼äµÄ rs- fc ½µµÍÓÐ ¹Ø £Û21 £Ý ¡£ACC/mPFC Çø¾ßÓзḻµÄ°¢Æ¬ÀàÊÜÌ壬 ²ÎÓë °¢Æ¬ÀàÄÚÔ´ÐÔÕòÍ´»úÖÆ £Û22 £Ý ¡£Òò´Ë£¬ ÓÐЧÕë´Ì¿ÉÔöÇ¿ ÎÞÏÈÕ×Æ«Í·Í´»¼Õß vlPAG Óë ACC/ mPFC Ö®¼äÒì³£ ½µµÍµÄ rs- fc ״̬£¬ ʹ MwoA »¼ÕßÊܵ½Ëðº¦µÄ DPMS Ç÷ÓÚÕý³£×´Ì¬¡£ ÁõºêΰµÈ £Û12 £Ý Õë´Ì×ãÁÙÆüµÄÑо¿½á¹ûÏÔʾ£¬ Õë´Ì ºó( Óë HC Ïà±È) Æ«Í·Í´»¼Õß×ó²àº£ÂíÅԻء¢ Ë«²à¿Û ´ø»ØºÍ×ó²à½Ç»ØÖ®¼äµÄ¹¦ÄÜÁ¬½ÓÔö¸ß¡£ÉÏÊöÏÔʾ µÄÄÔÇø´æÔÚÍ´¾õ´«µ¼Í¨Â·¡¢ ÇûÌå¸Ð¾õƤ²ãºÍÌÛÍ´ ¾ØÕóµÈ£¬ ²ÎÓëÕë´Ìµ÷½ÚÖÐÊàÐÔÌÛÍ´µÄ¸Ð¾õµ÷½Ú¡£ Zhang µÈ £Û14 £Ý µÄ ICA ·ÖÎöÑо¿½á¹ûÏÔʾ£¬ Õë´ÌÇ°ºó±È ½Ï£¬ MwoA »¼ÕßÒÔÏÂÄÔÇø½µµÍµÄ rs- fc µÃµ½ÌáÉý£¬ °üÀ¨ ¶î FPN( Ë«²à¶îÉϻء¢ ¶îÄÚ²à»ØºÍ¶¥ÏÂСҶ) Óë DMN ( ШǰҶ¡¢ ºó¿Û´øƤ²ãºÍ¿Û´ø»Ø) ¡¢ ò¨ÉÏ»Ø( superior temporal gyrus£¬ STG) ¡¢ò¨ ÖÐ »Ø ( middle temporal gyrus£¬MTG) ºÍÔµÖлصȡ£FPN ÍøÂç £Û23 £Ý ±»ÈÏΪÔÚÄÚ Ô´ÐÔÌÛÍ´ £Û24 £Ý ÖоßÓÐÖØÒª×÷Óá£DMN ÍøÂç £Û25 £Ý ÓëÏ°µÃ ÐÔÐÐΪ¡¢ ÈÏÖª¡¢ ÇéÐ÷ºÍ×¢ÒâÁ¦µÄ²úÉú¾ßÓÐÖØÒªÓ°Ïì¡£ DMN ËðÉËÓë·´¸´µÄÆ«Í·Í´·¢×÷ÓÐ¹Ø £Û26 £Ý ¡£Òò´Ë£¬ ÈÏ ÎªÕë´ÌÖÎÁƿɵ÷½ÚÊÜËðµÄÄÔ¹¦ÄÜÍøÂç rs- fc£¬ ·¢»ÓÔ¤ ·ÀÐÔÖÎÁÆ MwoA µÄ×÷ÓûúÖÆ¡£ Li µÈ £Û15 £Ý ²ÉÓà ICA ·½·¨£¬ MwoA »¼ÕßÕë´ÌÇ°£¬ ×ó ²àÖÐÑëÇ°»Ø¡¢ ×ó²àÔµÉϻء¢ ×ó²àÖÐÑëºó»ØÓë rFPN Ö® ¼ä½µµÍµÄ rs- fc µÃµ½ÌáÉý£¬ Ïà¹Ø·ÖÎöÏÔʾ¸Ã rs- fc Ô½ ¸ß£¬ VAS ·ÖÖµÔ½µÍ¡£½øÒ»²½ DTI Ñо¿·¢ÏÖ£¬ ´ÓÇðÄÔ µ½ 3 ¸ö ROI ÇøµÄ 3 ¸öÉñ¾ÏËάÓë½âÆÊλÖûù±¾ÎÇ ºÏ¡£ÕâЩÏËά¾¹ýÍâÄÒºÍÄÚÄҵĺóÖ«£¬ ÊÇÇðÄÔ·øÉä µÄ·¾¶Ö®Ò»¡£ÇðÄÔµÄÇ°·øÉäºÍºó·øÉäÖ±½ÓÓë¸Ð¾õ Ïà¹Ø £Û27- 28 £Ý Zhao µÈ £Û16 £Ý ReHo ·ÖÎöÏÔʾ£¬ ÖÎÁÆ×éÔÚÇðÄÔ¡¢ ACC¡¢ STG ºÍ¸¨ÖúÔ˶¯Çø( supplementary motor area£¬ SMA) ReHo Öµ½Ï¶ÔÕÕ×éÏÔÖøÔö¸ß; ÔÚº£ÂíÇø¡¢ ¶îÖÐ»Ø ( middle frontal gyrus£¬MFG) ºÍ MTG Çø ReHo ÖµÏÔÖø µÍÓÚ¶ÔÕÕ×é¡£ÖÎÁÆ×éÔÚÄÔµº ReHo ÖµÉÏÉý£¬ Ïà¹Ø·Ö Îö·¢ÏÖÓë VAS ÌÛÍ´·ÖÖµ³Ê¸ºÏà¹Ø¡£´ËÍâºó¿Û´øƤ ²ã( posterior cingulate cortex£¬PCC) ÓëШǰҶµÈÄÔÇø ½öÔÚÖÎÁÆ×éÖз¢ÏÖ ReHo Öµ¸Ä±ä£¬ ¸ÃÄÔÇøÊÇ DMN µÄ ÖØÒª×é³É¡£DMN ÊÇ»¼Õß´¦ÓÚÏà¶Ô “¾²Ï¢” £¬ ¼È²»¶ÔÖÜ Î§»·¾³/ʼþ²úÉú×¢ÒâʱËù´æÔÚµÄÄÔ¹¦ÄÜÍøÂç¡£µ± »úÌå¶ÔÌÛÍ´¹Øעʱ£¬ DMN Ïûʧ; ¶øµ±»¼Õ߶ÔÓÚÌÛÍ´ µÄ¹Ø×¢¼õÉÙ( ÒÔÍâÔÚ¸ÉÈÅ¡¢ ˼¿¼ÈÎÎñÀ´×ªÒÆ»¼Õß×¢ ÒâÁ¦) ʱ£¬ DMN ´æÔÚ£¬ Òò´Ë DMN ±»ÈÏΪÓ뻼Õ߶ÔÌÛ Í´µÄ×¢ÒâÁ¦ÓÐ¹Ø £Û29 £Ý ¡£ÔÚÆ«Í·Í´·¢×÷ʱ£¬ ÇðÄÔÇøÓëÌÛ Í´µ÷½ÚÄÔÍøÂç/Ƥ²ãÖ®¼äµÄ¹¦ÄÜÁ¬½ÓÊܵ½Ó°Ïì £Û30 £Ý £¬ ·¢×÷ÆÚÇðÄÔÓë×¢ÒâÍøÂçÖ®¼äµÄ¹¦ÄÜÁ¬½Ó·¢Éú¸Ä ±ä £Û31 £Ý £¬ Ìáʾƫͷʹ·¢×÷´ÎÊýµÄÔö¼Ó£¬¿Éµ¼ÖÂÈÏÖª¹¦ ÄܵĽøÒ»²½Ë𺦡£ÓÉÓÚ ACC ÊÇÁ½×鲻ͬµÄѨλÕë ´Ì×éËù¹²ÓÐµÄ ReHo ÖµÉý¸ßÄÔÇø£¬ Òò´Ë£¬ ÈÏΪ¸ÃÇø¿É ÄÜÊÇÕë´ÌÖÎÁƶÔÆ«Í·Í´Õë´ÌµÄ¹²Í¬×÷ÓÃÄÔÇø¡£ÔçÆÚ Ñо¿ÏÔʾ £Û32 £Ý £¬ ÄÔµº¡¢ ÇðÄÔºÍ ACC µÈÇø²ÎÓëÌÛÍ´µÄ¼Ç Ò䣬 Ó°Ï컼Õ߶ÔÌÛÍ´µÄ¸ÐÊܾÀú¡£Òò´Ë£¬ ÈÏΪÖÎÁÆ×é Õë´Ì¿Éͨ¹ý¶ÔÆ«Í·Í´Ïà¹ØÄÔÇøµ÷½Ú£¬ ²¢ÇÒµ÷½Ú»¼Õß µÄ¾«ÉñÐÄÀíÓëÉúÀíÎÈ̬£¬ ´ïµ½¼ÓǿֹʹÓëÑÓ³¤ÁÆЧ µÄÄ¿µÄ¡£ ¹ÈÌÎµÈ £Û17 £Ý µÄ MRS Ñо¿Í¨¹ý¹Û²ìÓÒ²àÇðÄÔºÍ¿Û ´øÇ°»Ø N- ÒÒõ£ÃŶ¬°±Ëá( N- acetylas- partate£¬NAA) / ¼¡Ëá( creatine£¬Cr) ¸´ºÏÎï¡¢ µ¨¼î¸´ºÏÎï( choline£¬ Cho) /Cr ²îÖµ£¬ ½á¹ûÏÔʾÕë´Ì¿ÉÓ°ÏìÆ«Í·Í´»¼ÕßÓÒ ²àÇðÄ﵀ NAA/Cr ²îÖµ¡£Ñо¿ NAA µÄº¬Á¿ÄÜ·´Ó³ Éñ¾ÔªÃܶȺ͹¦ÄÜ £Û33 £Ý £¬ NAA º¬Á¿Ï½µ¿É´ú±íÉñ¾ ÔªËðÉ˼°ÏàÓ¦¹¦ÄܵÄȱʧ£¬ ·´Ó³Éñ¾ÏµÍ³¼²²¡µÄ·¢ Éú £Û34 £Ý £¬ ¶ø Cr ¼´Ê¹ÔÚ²¡Àí״̬ÏÂÒ²³£³ÊÏÖÎȶ¨×´ ̬ £Û35 £Ý ¡£¹ýÍù²¨Æ×Ñо¿ÏÔʾ£¬ Æ«Í·Í´»¼ÕßµÄ NAA ºÍ Cho Ïà¶Ô±ÈֵϽµ £Û33 £Ý ¡£¾Õë´ÌºóÏàÓ¦²¿Î»µÄ NAA/ Cr ˮƽµÄÔö¸ß£¬ ÌáʾÉñ¾ÔªÏ¸°ûÔöÖ³ºÍÉñ¾Ôª´úл µÄ»îÔ¾¡£Òò´Ë£¬ µçÕë¿É¸ÄÉÆÆ«Í·Í´»¼ÕßÓÒ²àÇðÄ﵀ Éñ¾Ôª´úл£¬ ´Ó¶øÓ°ÏìÍ´¾õ´«µ¼´ïµ½ÕòʹЧ¹û¡£ ËÄ¡¢ Õ¹Íû Æ«Í·Í´µÄÔ¤·ÀÓëÖÎÁÆÊÇÏÖ´úҽѧµÄÄÑÌ⡣ƫͷ Í´»¼ÕßµÄÌÛÍ´¸Ð¾õ´¦ÀíÖÐÊà½Ï³£ÈËÃô¸Ð£¬ ´¦ÓÚ“ÎÈ Ì¬Ê§ºâ” ¡£fMRI ¼¼ÊõÊDzûÃ÷Æ«Í·Í´µÄ·¢²¡»úÖÆÖØÒª Ñо¿Í¾¾¶¡£¾²Ï¢Ì¬µÄ fMRI ¹¦ÄÜÁ¬½Ó¹Û²ìÏÔʾƫͷ Í´»¼ÕßÔÚ·¢×÷ÆÚÓë·¢×÷¼äÆÚÌÛ¾õ²úÉúºÍÌÛ¾õÒÖÖÆµÈ Ïà¹ØÍøÂ繦ÄÜÁ¬½ÓÒì³£±í´ï£¬ Ìáʾʹ¾õµ÷½Ú»úÖÆµÄ Ê§³££¬ µ¼ÖÂÆ«Í·Í´»¼ÕßÇ÷ÏòÍ´¾õ¹ýÃôµÄ²¡Çé·¢Õ¹£¬ ·´ Ó³³¤ÆÚµÄÍ·Í´¿É¶ÔÆ«Í·Í´»¼ÕßÄÔ¹¦ÄܵÄÓ°Ïì¡£ fMRI ·ÖÎö·½·¨Öð½¥Ç÷ÓÚÍêÉÆ£¬ µ«ÈÔÐèÒª½áºÏÆäËû·Ö Îö·½·¨£¬ »¥ÏàÃÖ²¹µ¥ÓÃÒ»ÖÖ·½·¨µÄ²»×㣬 ÀýÈçÉÏÊöÎÄ Ï×ÖвÉÓà ICA Óë SBA ·½·¨Ïà½áºÏ£¬ ²¹³äÑо¿½á¹û¾Ö ÏÞÐÔ¡¢ ÉúÎïЧӦ²»×ãµÄȱµã £Û36 £Ý ¡£Ìáʾ¹¦ÄÜÕûºÏ·ÖÎö ( SBA¡¢ ICA µÈ) Óë¾Ö²¿·ÖÎö( ICA¡¢ ALFF) ½áºÏÓ¦ÓÃµÄ ÓÅÊÆ¡£ ÓÉÓÚÆ«Í·Í´·¢²¡»úÖƵĸ´ÔÓÐÔ¡¢ fMRI ·ÖÎö·½·¨ µÄ¾ÖÏÞÐÔ¡¢ Ñо¿Éè¼ÆÓëʵ¼ùµÄÀ§ÄÑÐÔ£¬ Õë´ÌÖÎÁÆÆ«Í· Í´ fMRI ÖÐÊà»úÖÆÑо¿£¬ ÐèÒªÓиüÑϽ÷µÄÑо¿Éè¼ÆÓë ²ßÂÔ¡¢ ÇкÏÖÐÊà»úÖÆÓëÑо¿Ä¿µÄµÄ¿Æѧ¼ÙÉè¡¢ ¹æ·¶µÄ ²Ù×÷ÊØÔò£¬ ¼õÉÙ fMRI Ó°ÏìÒòËز¢²ÉÓò»Í¬µÄ·ÖÎö·½ ·¨ÑéÖ¤¡£ ½üÄêÀ´£¬ ´«Í³Õë¾ÄÊÖ·¨£¬ ѨλµÄÌØÒìÐÔºÍѨλÅä ÎéµÈ·½ÃæµÄ»úÖÆÑо¿¶¼ÊÇÐí¶à¹úÄÚÍâѧÕßÑо¿µÄÈÈ µã¡£Í¨¹ý fMRI ¼¼Êõ²ûÊöѨλµÄÖÐÊàЧӦÌص㣬 ÀýÈç ×ãÈýÀïѨºÍ¹ØԪѨµÄÖÐÊàÏà¶ÔÌØÒìÐÔ £Û37 £Ý ÓëÌ«³å Ѩ £Û38 £Ý µÄÌÛÍ´ÖÐÊàÏìÓ¦ÌØÕ÷µÈ¡£fMRI ¼¼Êõ½áºÏѨλ µÄÌØÒìÐÔ£¬ ѨλµÄÅäÎé×÷ÓõÈÓ¦ÓÃÑо¿£¬ ½øÒ»²½Ìṩ ¸ü¾ßÁÙ´²Óëרҵָµ¼ÒâÒåµÄÑо¿Ë¼Â·¡£ À´Ô´£ºÖлªÕë¾Äµç×ÓÔÓÖ¾ ×÷ÕߣºÑÕÃúº½ ²ÌÒÀŠp ÅὨ |